Building a Rapid Learning Health Care System for Oncology: Why CancerLinQ Collects Identifiable Health Information to Achieve Its Vision

2016 ◽  
Vol 34 (7) ◽  
pp. 756-763 ◽  
Author(s):  
Alaap Shah ◽  
Andrew K. Stewart ◽  
Andrej Kolacevski ◽  
Dina Michels ◽  
Robert Miller

The ever-increasing volume of scientific discoveries, clinical knowledge, novel diagnostic tools, and treatment options juxtaposed with rising costs in health care challenge physicians to identify, prioritize, and use new information rapidly to deliver efficient and high-quality care to a growing and aging patient population. CancerLinQ, a rapid learning health care system in oncology, is an initiative of the American Society of Clinical Oncology and its Institute for Quality that addresses these challenges by collecting information from the electronic health records of large numbers of patients with cancer. CancerLinQ is first and foremost a quality measurement and reporting system through which oncologists can harness the depth and power of their patients’ clinical records and other data to assess, monitor, and improve the care they deliver. However, in light of privacy and security concerns with regard to collection, use, and disclosure of patient information, this article addresses the need to collect protected health information as defined under the Health Insurance Portability and Accountability Act of 1996 to drive rapid learning through CancerLinQ.

2018 ◽  
Vol 30 (3) ◽  
pp. 161-168 ◽  
Author(s):  
Stuart McLennan ◽  
Hannes Kahrass ◽  
Susanne Wieschowski ◽  
Daniel Strech ◽  
Holger Langhof

2016 ◽  
Vol 23 (5) ◽  
pp. 314 ◽  
Author(s):  
R. Pataky ◽  
C.R. Baliski

Background Breast-conserving surgery (bcs) is the preferred surgical approach for most patients with early-stage breast cancer. Frequently, concerns arise about the pathologic margin status, resulting in an average reoperation rate of 23% in Canada. No consensus has been reached about the ideal reoperation rate, although 10% has been suggested as a target. Upon undergoing reoperation, many patients choose mastectomy and breast reconstruction, which add to the morbidity and cost of patient care. We attempted to identify the cost of reoperation after bcs, and the effect that a reduction in the reoperation rate could have on the B.C. health care system.Methods A decision tree was constructed to estimate the average cost per patient undergoing initial bcs with two reoperation frequency scenarios: 23% and 10%. The model included the direct medical costs from the perspective of the B.C. health care system for the most common surgical treatment options, including breast reconstruction and postoperative radiation therapy.Results Costs ranged from a low of $8,225 per patient with definitive bcs [95% confidence interval (ci): $8,061 to $8,383] to a high of $26,026 for reoperation with mastectomy and delayed reconstruction (95% ci: $23,991 to $28,122). If the reoperation rate could be reduced to 10%, the average saving would be $1,055 per patient undergoing attempted bcs (95% ci: $959 to $1,156). If the lower rate were to be achieved in British Columbia, it would translate into a savings of $1.9 million annually.Summary The implementation of initiatives to reduce reoperation after bcs could result in significant savings to the health care system, while potentially improving the quality of patient care.


2017 ◽  
Vol 65 (11) ◽  
pp. 2446-2451 ◽  
Author(s):  
Melissa M. Garrido ◽  
Richard M. Allman ◽  
Steven D. Pizer ◽  
James L. Rudolph ◽  
Kali S. Thomas ◽  
...  

2013 ◽  
Vol 43 (s1) ◽  
pp. S16-S27 ◽  
Author(s):  
Ruth R. Faden ◽  
Nancy E. Kass ◽  
Steven N. Goodman ◽  
Peter Pronovost ◽  
Sean Tunis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document